Skip to main contentSkip to institutions
Medical TourismReport #3Featured

Medical Tourism & International Healthcare Collaboration

China Healthcare Guide Research
Updated:

Executive Summary

China is emerging as a global medical tourism hub, led by the Boao Lecheng zone in Hainan which achieved 865,300 visits in 2025 (+109% YoY). Offering 50-70% cost savings compared to Western nations and a unique "TCM Plus" integrative care model, China is attracting a growing number of international patients.

Key Statistics

865,300

Patient Visits 2025

+109% YoY

50-70%

Cost Savings vs West

Source: MedChina

59

Visa-Free Countries

Source: Hainan Policy

180+

Global Partners

Source: Boao Lecheng

Key Findings

  • 1Boao Lecheng established as China's primary AP medical tourism hub target by 2026
  • 2Treatment costs in China are 50-70% lower than in Western countries
  • 3Parkway Pantai and other international operators are expanding China-owned operations
  • 4High-end "TCM Plus" integrative care is a unique global draw
  • 5Speedier diagnosis and treatment pathways bypassing rigid referral systems

A Strategic Shift in Global Patient Mobility

China is rapidly positioning itself as an emerging and compelling destination for medical tourism, leveraging its advanced technology, skilled professionals, and competitive pricing.

The Boao Lecheng 2026 Vision

The Boao Lecheng International Medical Tourism Pilot Zone in Hainan is at the center of this strategy.

  • 2026 Goal: To become the world's leading medical tourism destination and the primary center for the Asia-Pacific region.
  • Access Point: Designated as China's second medical device approval point, enabling "zero-wait" access to global innovations.
  • Growth: 865,300 patient visits in 2025, a 109.18% year-over-year increase.

Competitive Advantages: Cost & Speed

As highlighted by platforms like MedChina, the value proposition for international patients is significant:

  • Major Cost Savings: World-class medical treatments are often 50-70% lower in cost than in many Western countries.
  • Efficient Pathways: A focus on speedier diagnosis and treatment processes, offering a faster alternative to countries with rigid referral systems.

International Trust & Integration

Leading global players are already embedded in the ecosystem:

  • Parkway Pantai: The Singaporean operator of China's first foreign-owned hospital is expanding its appeal to international medical tourists.
  • Trusted Platforms: Sites like MedBridge NZ and MedicalTourism.com increasingly feature China as a top destination, emphasizing the safety and quality of the ancient-meets-modern medical blend.

The "TCM Plus" Integrative Model

China's unique selling proposition is the combination of cutting-edge modern procedures with Traditional Chinese Medicine (TCM).

  • Holistic Care: Integrating TCM into oncology and rehabilitation to manage side effects and improve long-term outcomes.
  • Modernized TCM: AI-powered diagnostics and computer-vision guided therapy have made TCM more accessible and standardized for a global audience.

"The zone has been designated as China's second medical device approval access point after Shanghai, creating a regulatory sandbox enabling accelerated introduction of innovative international medical technologies." — Hainan Free Trade Port Authority

Last updated: